Alkermes Plc (ALKS)
34.91
+1.36
(+4.05%)
USD |
NASDAQ |
Feb 06, 16:00
34.88
-0.03
(-0.09%)
After-Hours: 20:00
Alkermes SG&A Expense (TTM) : 661.32M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 191.46M |
| Krystal Biotech, Inc. | 136.75M |
| CorMedix, Inc. | 75.56M |
| Amicus Therapeutics, Inc. | 353.07M |
| Jazz Pharmaceuticals Plc | 1.772B |